Dyne Therapeutics, Inc. (DYN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Dyne Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.63x | -6.99x | -3.36x | -3.58x | -4.05x | -16.90x |
| P/B Ratio | 2.58x | 3.52x | 8.70x | 2.39x | 1.64x | 2.90x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 22.25x | 15.60x | 2.53x | 9.46x | 13.31x | 31.83x |
| Quick Ratio | 22.25x | 15.60x | 2.53x | 9.46x | 13.31x | 31.83x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.04x | 0.30x | 0.12x | 0.09x | 0.00x |
YoY = year-over-year change. Source: FMP..